NASDAQ Composite Index

NASDAQ Composite Index handeln
26.247,08 PKT +440,88 PKT +1,71 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 969427

ISIN XC0009694271


Analysen zu NASDAQ Composite Index-Werten

Datum Rating Analyst
05.04.11 Intel buy Kaufman Bros., LP
05.04.11 VeriSign outperform Credit Suisse Group
05.04.11 Dish Network outperform Credit Suisse Group
04.04.11 Vertex Pharmaceuticals outperform RBC Capital Markets
04.04.11 NVIDIA neutral UBS AG
04.04.11 Teva Pharmaceutical Industries neutral Credit Suisse Group
01.04.11 eBay kaufen Nasd@q Inside
01.04.11 BlackBerry neutral UBS AG
01.04.11 Logitech buy Vontobel Research
01.04.11 Ceragon Networks overweight Barclays Capital
01.04.11 QUALCOMM outperform Sanford C. Bernstein and Co., Inc.
31.03.11 Neogen neutral J.J.B. Hilliard, W.L. Lyons, Inc.
31.03.11 Expedia neutral UBS AG
31.03.11 Amazon overweight Morgan Stanley
31.03.11 Apple buy Needham & Company, LLC
31.03.11 Intel outperform Credit Suisse Group
31.03.11 Baidu.com buy Goldman Sachs Group Inc.
31.03.11 NVIDIA hold ThinkEquity Partners LLC
31.03.11 Salesforce hold Citigroup Corp.
30.03.11 Baidu.com kaufen Asia Investor
30.03.11 Biogen neutral UBS AG
30.03.11 Apple outperform Pacific Crest Securities Inc.
30.03.11 eBay buy Needham & Company, LLC
29.03.11 eBay neutral Wedbush Morgan Securities Inc.
29.03.11 eBay neutral UBS AG
29.03.11 BlackBerry sell Goldman Sachs Group Inc.
29.03.11 Akamai overweight Piper Jaffray & Co.
28.03.11 Oracle halten Hamburger Sparkasse AG (Haspa)
28.03.11 BlackBerry buy Société Générale Group S.A. (SG)
28.03.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
28.03.11 BlackBerry overweight Barclays Capital
28.03.11 Oracle overweight Barclays Capital
28.03.11 Teva Pharmaceutical Industries overweight Barclays Capital
28.03.11 Apple overweight Piper Jaffray & Co.
25.03.11 BlackBerry outperform Credit Suisse Group
25.03.11 Oracle outperform Credit Suisse Group
25.03.11 Oracle buy Stifel, Nicolaus & Co., Inc.
25.03.11 Alexion Pharmaceuticals outperform Oppenheimer & Co. Inc.
25.03.11 Spectrum Pharmaceuticals outperform RBC Capital Markets
25.03.11 Oracle buy UBS AG